Correlation Between Biosyent and Cipher Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Biosyent and Cipher Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biosyent and Cipher Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Biosyent and Cipher Pharmaceuticals, you can compare the effects of market volatilities on Biosyent and Cipher Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biosyent with a short position of Cipher Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biosyent and Cipher Pharmaceuticals.

Diversification Opportunities for Biosyent and Cipher Pharmaceuticals

0.26

Correlation Coefficient

Biosyent  Cipher Pharmaceuticals

Modest diversification

The 3 months correlation between Biosyent and Cipher is 0.26. Overlapping area represents the amount of risk that can be diversified away by holding Biosyent and Cipher Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cipher Pharmaceuticals and Biosyent is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biosyent are associated (or correlated) with Cipher Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cipher Pharmaceuticals has no effect on the direction of Biosyent i.e., Biosyent and Cipher Pharmaceuticals go up and down completely randomly.

Pair Corralation between Biosyent and Cipher Pharmaceuticals

Given the investment horizon of 90 days Biosyent is expected to generate 0.31 times more return on investment than Cipher Pharmaceuticals. However, Biosyent is 3.2 times less risky than Cipher Pharmaceuticals. It trades about -0.01 of its potential returns per unit of risk. Cipher Pharmaceuticals is currently generating about -0.04 per unit of risk. If you would invest  1,130  in Biosyent on December 30, 2024 and sell it today you would lose (15.00) from holding Biosyent or give up 1.33% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Biosyent  vs.  Cipher Pharmaceuticals

Biosyent

Risk-Adjusted Performance

Very Weak

Over the last 90 days Biosyent has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Biosyent is not utilizing all of its potentials. The recent stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Cipher Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Cipher Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's technical indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

Pair Trading with Biosyent and Cipher Pharmaceuticals

The main advantage of trading using opposite Biosyent and Cipher Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biosyent position performs unexpectedly, Cipher Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cipher Pharmaceuticals will offset losses from the drop in Cipher Pharmaceuticals' long position.

The idea behind Biosyent and Cipher Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.